Raptor Pharmaceutical Corp Business Development
Raptor Pharmaceutical Corp reported Business Development of $20.90 million for the 12-month period ending 2012-08-31, per its 10-K filed 2012-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2012-11-14
- Raptor Pharmaceutical Corp business development for fiscal 2012 was $20.90M, a 84.96% increase from fiscal 2011.
- Raptor Pharmaceutical Corp business development for fiscal 2011 was $11.30M, a 82.26% increase from fiscal 2010.
- Raptor Pharmaceutical Corp business development for fiscal 2010 was $6.20M, a 51.22% increase from fiscal 2009.
- Raptor Pharmaceutical Corp business development for fiscal 2009 was $4.10M.
| Period end | Business Development 12 month |
|---|---|
| 2012-08-31 | $20.90M 10-K · filed 2012-11-14 |
| 2011-08-31 | $11.30M 10-K · filed 2012-11-14 |
| 2010-08-31 | $6.20M 10-K · filed 2012-11-14 |
| 2009-08-31 | $4.10M 10-K · filed 2012-11-14 |